Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans.

Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans. Recently it has been shown in animal models of amyotrophic lateral sclerosis (ALS) that stem cells significantly slow the progression of the disease and prolong survival. We have evaluated the feasibility and safety of a method of intraspinal cord implantation of autologous mesenchymal stem cells (MSCs) in a few well-monitored patients with ALS. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases Pubmed

Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans.

Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases , Volume 4 (3): 4 – Dec 29, 2003

Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans.


Abstract

Recently it has been shown in animal models of amyotrophic lateral sclerosis (ALS) that stem cells significantly slow the progression of the disease and prolong survival. We have evaluated the feasibility and safety of a method of intraspinal cord implantation of autologous mesenchymal stem cells (MSCs) in a few well-monitored patients with ALS.

Loading next page...
 
/lp/pubmed/stem-cell-therapy-in-amyotrophic-lateral-sclerosis-a-methodological-W058eU1080

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1466-0822
DOI
10.1080/14660820310014653
pmid
13129802

Abstract

Recently it has been shown in animal models of amyotrophic lateral sclerosis (ALS) that stem cells significantly slow the progression of the disease and prolong survival. We have evaluated the feasibility and safety of a method of intraspinal cord implantation of autologous mesenchymal stem cells (MSCs) in a few well-monitored patients with ALS.

Journal

Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron DiseasesPubmed

Published: Dec 29, 2003

There are no references for this article.